Do neck levels negative on initial CT need to be dissected after definitive radiation therapy with or without chemotherapy?

Head and Neck

Volumn 30, Issue 8, 2008, Pages 1090-1098

  Rao, Nikhil G ^a   Sanguineti, Giuseppe ^a   Chaljub, Gregory ^a   Newlands, Shawn D ^a   Qiu, Suimin ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chemotherapy; Extent; Neck dissection; Radiation; Selective

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; IMAGE ENHANCEMENT; LYMPH NODE; MALE; NECK DISSECTION; OROPHARYNX CANCER; PHARYNX CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TONGUE CANCER; TONSIL CANCER;

ADULT; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 50249155307     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20842     Document Type: Article

References (61)

1. Clayman GL, Johnson CJ II, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemora-diotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001;127:135-139.
2. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
3. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:526-531.
4. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986;12:733-740.
5. Weisman RA, Robbins KT. Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin North Am 1998;31:773-784.
6. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999;21:606-613.
7. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
8. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950-956.
9. Wanebo H, Chougule P, Ready N, et al. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001;8:644-650.
10. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-566.
11. Frank DK, Hu KS, Culliney BE, et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 2005;115:1015-1020.
12. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423.
13. Kutler DI, Patel SG, Shah JP. The role of neck dissection following definitive chemoradiation. Oncology (Williston Park) 2004;18:993-998; discussion 999, 1003-1004, 1007.
14. Mendenhall WM, Villaret DB, Amdur RJ, Hinerman RW, Mancuso AA. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:1012-1018.
15. Wang SJ, Wang MB, Yip H, Calcaterra TC. Combined radiotherapy with planned neck dissection for small head and neck cancers with advanced cervical metastases. Laryngoscope 2000;110:1794-1797.
16. Lango M, Ende K, Ahmad S, Feigenberg SJ, Ridge JA.Neck dissection following organ preservation protocols prolongs feeding tube dependence in patients with advanced head and neck cancer. ASCO 2006; Abstract 5525.
17. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 2005;131:965-969.
18. Doweck I, Robbins KT, Mendenhall WM, Hinerman RW, Morris C, Amdur R. Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy? Head Neck 2003;25:960-967.
19. Boyd TS, Harari PM, Tannehill SP, et al. Planned post-radiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998;20:132-137.
20. Byers RM, Clayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodi-gestive tract: patterns of regional failure. Head Neck 1999;21:499-505.
21. Pathak KA, Das AK, Agarwal R, et al. Selective neck dissection (I-III) for node negative and node positive necks. Oral Oncol 2006;42:837-841.
22. Ambrosch P, Kron M, Pradier O, Steiner W. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:180-187.
23. Zhang B, Xu ZG, Qi YF, Wang XL, Tang PZ. [Efficacy of selective neck dissection: a review of 123 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of head and neck]. Zhonghua Er Bi Yan Hou Ke Za Zhi 2003;38:123-127.
24. Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg 1999;125:388-396.
25. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 2006;24:1421-1427.
26. Ojiri H, Mendenhall WM, Stringer SP, Johnson PL, Mancuso AA. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52:420-428.
27. Ojiri H, Mancuso AA, Mendenhall WM, Stringer SP. Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol 2002;23:1627-1631.
28. Velazquez RA, McGuff HS, Sycamore D, Miller FR. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130:74-77.
29. Sanguineti G, Endres EJ, Gunn BG, Parker B. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys 2006;66:931-938.
30. Riffenburgh. Statistics in medicine, 2nd ed. Burlington, MA: Elsevier; 2006.
31. Hall E, Giaccia A. Radiobiology for the radiologist, 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006.
32. Ang KK, Garden A. Radiotherapy for head and neck cancers: indications and techniques, 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2006.
33. Sanguineti G, Corvo R, Benasso M, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999;21:223-228.
34. Roy S, Tibesar RJ, Daly K, et al. Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy. Head Neck 2002;24:474-481.
35. Stenson KM, Huo D, Blair E, et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 2006;116:33-36.
36. Thariat J, Ahamad A, Garden A, et al. Prediction of neck dissection requirement following definitive radiotherapy for head and neck squamous cell carcinoma. In: Proceedings of the American Society for Therapeutic Radiology and Oncology, 48th Annual Meeting, Philadelphia, PA, 2006.
37. Sewall GK, Palazzi-Churas KL, Richards GM, Hartig GK, Harari PM. Planned postradiotherapy neck dissection: rationale and clinical outcomes. Laryngoscope 2007;117:121-128.
38. Yao M, Hoffman HT, Chang K, et al. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy? Int J Radiat Oncol Biol Phys 2007;68:707-713.
39. Yao M, Smith RB, Graham MM, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2005;63:991-999.
40. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694-697.
41. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181.
42. Gourin CG, Williams HT, Seabolt WN, Herdman AV, Howington JW, Terris DJ. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 2006;116:705-710.
43. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999;125:401-405.
44. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406.
45. Terrell JE, Welsh DE, Bradford CR, et al. Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope 2000;110:620-626.
46. Laverick S, Lowe D, Brown JS, Vaughan ED, Rogers SN. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg 2004;130:149-154.
47. Kuntz AL, Weymuller EA Jr. Impact of neck dissection on quality of life. Laryngoscope 1999;109:1334-1338.
48. Cappiello J, Piazza C, Giudice M, De Maria G, Nicolai P. Shoulder disability after different selective neck dissections (levels II-IV versus levels II-V): a comparative study. Laryngoscope 2005;115:259-263.
49. Chepeha DB, Taylor RJ, Chepeha JC, et al. Functional assessment using Constant's Shoulder Scale after modified radical and selective neck dissection. Head Neck 2002;24:432-436.
50. Fletcher GH. Biological and clinical basis of radiosensitivity. Springfield, IL: Charles C. Thomas; 1974. pp 485-501.
51. Ambrosch P, Brinck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Williston Park) 1996;10:1221-1226; discussion 1226, 1229.
52. Barrera JE, Miller ME, Said S, Jafek BW, Campana JP, Shroyer KR. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope 2003;113:892-896.
53. Devaney SL, Ferlito A, Rinaldo A, Devaney KO. Pathologic detection of occult metastases in regional lymph nodes in patients with head and neck cancer. Acta Otolaryngol 2000;120:344-349.
54. Enepekides DJ, Sultanem K, Nguyen C, Shenouda G, Black MJ, Rochon L. Occult cervical metastases: immunoperoxidase analysis of the pathologically negative neck. Otolaryngol Head Neck Surg 1999;120:713-717.
55. Woolgar JA. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg 1999;37:181-186.
56. Shores CG, Yin X, Funkhouser W, Yarbrough W. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:937-942.
57. Pohar S, Brown R, Newman N, Koniarczyk M, Hsu J, Feiglin D. What does pet imaging add to conventional staging of head and neck cancer patients? Int J Radiat Oncol Biol Phys 2007;68:383-387.
58. Schwartz DL, Ford E, Rajendran J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005;61:129-136.
59. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005;24:1244-1251.
60. Kato Y, Uzawa K, Saito K, et al. Gene expression pattern in oral cancer cervical lymph node metastasis. Oncol Rep 2006;16:1009-1014.
61. Schmalbach CE, Chepeha DB, Giordano TJ, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:295-302.